BLK vs EBS
BlackRock Inc (BLK) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BLK and EBS stock pages for the full models.
Not investment advice.